Evidence map›Paper›PMID 32669032›Full record

ArticleJournal of neurotrauma2021

Enoxaparin Attenuates Acute Lung Injury and Inflammasome Activation after Traumatic Brain Injury.

Nadine A Kerr, Juan Pablo de Rivero Vaccari, Cailey Weaver, W Dalton Dietrich, Tahir Ahmed, Robert W Keane

Open access · greenAbstract read
In one paragraph

Article in Journal of neurotrauma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neural-Cardiac Inflammasome Axis after Traumatic Brain Injury.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Inflammasome activation in traumatic brain injury and Alzheimer's disease.Translational research : the journal of laboratory and clinical medicine · 2023
    Review
  16. Inhibition of gp130 alleviates LPS-induced lung injury by attenuating apoptosis and inflammation through JAK1/STAT3 signaling pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nadine A KerrDepartment of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Juan Pablo de Rivero VaccariDepartment of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Cailey WeaverDepartment of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, Florida, USA.
W Dalton DietrichDepartment of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Tahir AhmedPulmonary Division, Mount Sinai Medical Center, Miami Beach, Florida, USA.
Robert W KeaneDepartment of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
University of Miami · USMount Sinai Medical Center · US

Funding

Role of ASC in TBI-Mediated Systemic Inflammation.R01NS113969 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DE RIVERO VACCARI, JUAN PABLO, KEANE, ROBERT W · 2020 to 2024
$1.9M
NINDS NIH HHS R01 NS113969
6 · The paper itself

Abstract

Traumatic brain injury (TBI) patients frequently develop cardiopulmonary system complications such as acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). However, the mechanism by which TBI causes ALI/ARDS is not fully understood. Here, we used a severe TBI model to examine the effects of a low-molecular-weight heparin, enoxaparin, on inflammasome activation and lung injury damage. We investigated whether enoxaparin inhibits ALI and inflammasome signaling protein expression in the brain and lungs after TBI in mice. C57/BL6 mice were subjected to severe TBI and were treated with vehicle or 1 mg/kg of enoxaparin 30 min after injury. Lung and brain tissue were collected 24 h post-TBI and were analyzed by immunoblotting for expression of the inflammasome proteins, caspase-1 and interleukin (IL)-1β. In addition, lung tissue was collected for histological analysis to determine ALI scoring and neutrophil and macrophage infiltration post-injury. Our data show that severe TBI induces increased expression of inflammasome proteins caspase-1 and IL-1β in the brain and lungs of mice after injury. Treatment with enoxaparin attenuated inflammasome expression in the brain and lungs 24 h after injury. Enoxaparin significantly decreased ALI score as well as neutrophil and macrophage infiltration in lungs at 24 h after injury. This study demonstrates that enoxaparin attenuates ALI and inhibits inflammasome expression in the brain and lungs after TBI. These findings support the hypothesis that inhibition of the neural-respiratory inflammasome axis that is activated after TBI may have therapeutic potential.

Indexed as

Acute Lung InjuryAnimalsAnticoagulantsBrain Injuries, TraumaticDisease Models, AnimalEnoxaparinInflammasomesMaleMiceMice, Inbred C57BLNeutrophil InfiltrationAnticoagulantsEnoxaparinInflammasomesacute lung injuryenoxaparininflammasometraumatic brain injury

Identifiers

PMID32669032
PMCPMC7898405
OpenAlexW3042697383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.